Depression and anxiety are co-morbid but dissociable in mild Parkinson's disease: A prospective longitudinal study of patterns and predictors

被引:28
|
作者
Wee, Natalie [2 ]
Kandiah, Nagaendran [1 ,2 ]
Acharyya, Sanchalika [2 ]
Chander, Russell J. [1 ]
Ng, Aloysius [1 ]
Au, Wing Lok [1 ,2 ]
Tan, Louis C. S. [1 ,2 ]
机构
[1] Natl Neurosci Inst, Dept Neurol, 11 Jalan Tan Tack Seng, Singapore 308433, Singapore
[2] Duke NUS Grad Med Sch, 8 Coll Rd, Singapore 169857, Singapore
基金
新加坡国家研究基金会;
关键词
Depression; Anxiety; Parkinson's disease; Non-motor; Longitudinal; Generalised Estimating Equations; EXCESSIVE DAYTIME SLEEPINESS; OLDER-ADULTS; APATHY; PREVALENCE; DISORDERS; VALIDATION; SCALES;
D O I
10.1016/j.parkreldis.2015.12.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Depression and anxiety are common in Parkinson's disease (PD) and contribute significantly to a reduced quality of life in PD patients. Though they often co-exist, it is unclear whether depression and anxiety result from a shared pathological process. We studied the longitudinal course and determinants of depression and anxiety in PD in order to understand which factors contribute to the development of these symptoms. Methods: We conducted a prospective longitudinal study of 89 mild PD patients over 18 months, measuring depressive and anxiety symptoms at 6 monthly intervals using the Geriatric Depression Scale and Hospital Anxiety and Depression Scale - 'Anxiety' subscale. Univariate and multivariate Generalised Estimating Equations were used to investigate the course of depression and anxiety and their association with demographic factors, motor measures, non-motor symptoms, and pharmacological factors. Results: Depression and anxiety were co-morbid in 13.5% of the sample. Depressive symptoms remained relatively stable while anxiety symptoms improved over the course of 18 months. Severity of depressive symptoms was associated with female gender, motor fluctuations, apathy, and anxiety, while severity of anxiety was associated with older age, higher educational attainment, shorter disease duration, younger age of disease onset, and excessive daytime sleepiness. Conclusions: Although depression and anxiety are frequently co-morbid in PD, they were dissociable from each other. They had distinct trajectories and different longitudinal relationships with demographic, motor, and non-motor factors that were unique to each disorder. (C) 2015 Published by Elsevier Ltd.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 50 条
  • [31] Disease management for co-morbid depression and anxiety in diabetes mellitus: design of a randomised controlled trial in primary care
    Stoop, Corinne H.
    Spek, Viola R. M.
    Pop, Victor J. M.
    Pouwer, Francois
    BMC FAMILY PRACTICE, 2011, 12
  • [32] A study of the prevalence of restless legs syndrome in previously untreated Parkinson's disease patients: Absence of co-morbid association
    Angelini, Monica
    Negrotti, Anna
    Marchesi, Elena
    Bonavina, Giuseppe
    Calzetti, Stefano
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 310 (1-2) : 286 - 288
  • [33] Prospective study of anxiety and risk of Parkinson's disease
    Weisskopf, MG
    Chen, H
    Kawachi, I
    Ascherio, A
    MOVEMENT DISORDERS, 2002, 17 : S146 - S146
  • [34] Prospective predictors of care partner burden and depression in Parkinson's disease
    Whiteley, Nicole
    Pluim, Celina F.
    Split, Molly
    Tuazon, Angelie Cabrera
    Moore, Raeanne C.
    Litvan, Irene
    Lessig, Stephanie
    Filoteo, J. Vincent
    Schiehser, Dawn M.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 37 (09)
  • [35] Disease-specific or co-morbid factors - Which has the greatest impact on disability in Parkinson's disease?
    Shulman, L. M.
    Anderson, K. E.
    Gruber-Baldini, A. L.
    Reich, S. G.
    Fishman, P. S.
    Weiner, W. J.
    MOVEMENT DISORDERS, 2006, 21 : S509 - S509
  • [36] Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease
    Moonen, A. J. H.
    Wijers, A.
    Leentjens, A. F. G.
    Christine, C. W.
    Factor, S. A.
    Juncos, J.
    Lyness, J. M.
    Marsh, L.
    Panisset, M.
    Pfeiffer, R.
    Rottenberg, D.
    Ramos, C. Serrano
    Shulman, L.
    Singer, C.
    Slevin, J.
    McDonald, W.
    Auinger, P.
    Richard, I. H.
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (06) : 644 - 646
  • [37] Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function
    Ng, Aloysius
    Chander, Russell Jude
    Tan, Louis C. S.
    Kandiah, Nagaendran
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (09) : 1056 - 1060
  • [38] Longitudinal assessment of evolution and plasma biomarkers for depression and anxiety in Parkinson's disease
    Lin, J.
    Ou, R.
    Li, C.
    Wei, Q.
    Hou, Y.
    Zhang, L.
    Liu, K.
    Jiang, Q.
    Yang, T.
    Xiao, Y.
    Pang, D.
    Yu, Y.
    Zhao, B.
    Chen, X.
    Song, W.
    Yang, J.
    Wu, Y.
    Shang, H.
    MOVEMENT DISORDERS, 2023, 38 : S234 - S234
  • [39] Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease
    Shi, Yiwen
    Dobkin, Roseanne
    Weintraub, Daniel
    Cho, Hyunkeun R.
    Caspell-Garcia, Chelsea
    Bock, Meredith
    Brown, Ethan
    Aarsland, Dag
    Dahodwala, Nabila
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (09): : 1103 - 1112
  • [40] Predictors of anxiety in Parkinson's disease: results from a 3-year longitudinal cohort study
    Gibson, Jessie S.
    Flanigan, Joseph L.
    Patrie, James T.
    Dalrymple, W. Alex
    Harrison, Madaline B.
    NEUROLOGICAL SCIENCES, 2023, 44 (02) : 547 - 556